Molecular Mechanism of Mule in DNA Damage Response and Tumorigenesis

骡DNA损伤反应和肿瘤发生的分子机制

基本信息

  • 批准号:
    7584403
  • 负责人:
  • 金额:
    $ 31.57万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-01-01 至 2013-11-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Cancer remains a major killer that impacts a large number of new patients every year. One leading reason for cancer is an inappropriate response to DNA damage. Upon DNA damage, the cell will initiate apoptosis through the mitochondria apparatus when DNA damage is beyond repair. Once this cell death pathway is triggered, cytotoxic factors are released from mitochondria to activate caspases that induce apoptosis. An impaired apoptotic potential of damaged cells leads to continued cell division without restriction that frequently develops into cancer. Indeed, mis-regulation of apoptosis is associated with many cancers. Understanding the molecular mechanisms that regulate DNA damage signals and how they are transmitted to mitochondria to initiate apoptosis is therefore important for cancer research. Biochemical approaches are utilized to reconstitute DNA damage-induced apoptosis. Degradation of Mcl-1, a key anti-death protein, is required to trigger cytochrome c release from mitochondria upon DNA damage. Mcl-1 is degraded through the ubiquitin-proteasome pathway. In the ubiquitin-proteasome system, the ubiquitin ligases determine the specificity and timing of substrates destruction. A biochemical assay was established to search for such enzyme from human cell extracts, and a novel ubiquitin ligase Mule (Mcl-1 ubiquitin ligase e3) was cloned. Mule promotes ubiquitin modification of Mcl-1 through direct interaction through a BH3 domain, and Mule is indispensable for Mcl-1 mediated apoptotic pathway. Besides Mcl-1, Mule also ubiquitinates other substrates including p53 thus adding another intriguing link to the apoptosis pathway. In this proposal, the mechanism by which Mule activation and the differential regulation of Mule target different substrates in response to DNA damage signals will be investigated. The biological function of Mule in DNA damage response will be studied in Aim 1. Our newly generated Mule knockout mouse embryonic fibroblast cells will be utilized to study the function of Mule in DNA damage induced apoptosis and cell cycle checkpoints. We will also investigate the structure and function relationship of Mule, especially the requirement of the ubiquitin ligase activity of Mule for its function in DNA damage response in this aim. We will characterize the ubiquitination and degradation of Mcl-1 and p53 by Mule in Aim 2. Ubiquitin chain formation, E3 activity (Mule versus Mdm2), the contribution of Mcl-1 and p53 in Mule-dependent DNA damage response, and regulatory mechanisms of Mcl-1 and p53 ubiquitination will be investigated in this aim. In Aim 3, we will further characterize the interaction of Mule with its substrates; especially map the binding site of p53 to Mule. We will study how the interaction between Mule and substrates are regulated by DNA damage. More importantly, we will search for novel protein factors modulating Mule activity through tandem affinity purification. In Aim 4, we will put more focus on post- translation modification of Mule, especially phosphorylation of Mule in DNA damage response and discuss potential mechanisms involved in it. These experiments should reveal novel mechanisms mediating DNA damage signals and how they are transduced through Mule, thereby providing fundamental insights into regulatory networks controlling apoptosis and DNA damage response. A mechanistic understanding of this pathway will help us decipher how apoptosis is deregulated in cancer and potentially identify new targets for therapeutic intervention. PUBLIC HEALTH RELEVANCE: Misregulation of apoptosis is considered to be one of the major mechanisms for tumorigenesis, especially upon exposure to exogenous DNA damaging agents and during normal physiological processes. This proposal will disclose a novel mechanism mediating DNA damage signals, thereby providing fundamental insights into regulatory networks controlling apoptosis. A mechanistic understanding of this pathway will help us decipher how apoptosis is deregulated in cancer and potentially identify new targets for therapeutic intervention.
描述(由申请人提供):癌症仍然是每年影响大量新患者的主要杀手。癌症的一个主要原因是对DNA损伤的不适当反应。在DNA损伤时,当DNA损伤无法修复时,细胞将通过线粒体装置启动凋亡。一旦这种细胞死亡途径被触发,细胞毒性因子从线粒体释放以激活诱导凋亡的半胱天冬酶。受损细胞的凋亡潜力受损导致细胞不受限制地继续分裂,这经常发展成癌症。事实上,细胞凋亡的错误调节与许多癌症有关。因此,了解调节DNA损伤信号的分子机制以及它们如何传递到线粒体以启动细胞凋亡对癌症研究非常重要。利用生物化学方法来重建DNA损伤诱导的细胞凋亡。Mcl-1是一种关键的抗死亡蛋白,其降解是在DNA损伤时触发细胞色素c从线粒体释放所必需的。Mcl-1通过泛素-蛋白酶体途径降解。在泛素-蛋白酶体系统中,泛素连接酶决定底物破坏的特异性和时间。建立了从人细胞提取物中寻找这种酶的生化方法,并克隆了一种新的泛素连接酶Mule(Mcl-1 ubiquitin ligase e3)。Mule通过BH 3结构域的直接相互作用促进Mcl-1的泛素修饰,并且Mule是Mcl-1介导的凋亡途径不可或缺的。除了Mcl-1,Mule还泛素化其他底物,包括p53,从而增加了另一个有趣的凋亡途径。在这个提议中,将研究Mule激活和Mule针对不同底物响应DNA损伤信号的差异调节的机制。目的1将研究Mule在DNA损伤反应中的生物学功能。我们新产生的Mule基因敲除小鼠胚胎成纤维细胞将用于研究Mule在DNA损伤诱导的细胞凋亡和细胞周期检查点中的作用。我们还将研究Mule的结构与功能之间的关系,特别是Mule在DNA损伤反应中的功能对泛素连接酶活性的要求。我们将在Aim 2中描述Mule对Mcl-1和p53的泛素化和降解。本研究将探讨泛素链的形成、E3活性(Mule vs. Mdm 2)、Mcl-1和p53在Mule依赖性DNA损伤反应中的作用以及Mcl-1和p53泛素化的调控机制。在目标3中,我们将进一步表征Mule与其底物的相互作用,特别是定位p53与Mule的结合位点。我们将研究Mule和底物之间的相互作用如何受到DNA损伤的调节。更重要的是,我们将通过串联亲和纯化来寻找新的调节Mule活性的蛋白质因子。目的4将重点研究Mule的翻译后修饰,特别是Mule在DNA损伤反应中的磷酸化,并探讨其可能的作用机制,以期揭示DNA损伤信号的调控机制及其通过Mule的途径,从而为研究细胞凋亡和DNA损伤反应的调控网络提供基础性的认识。对这一途径的机制理解将有助于我们破译细胞凋亡在癌症中是如何失调的,并可能确定新的治疗干预靶点。公共卫生关系:细胞凋亡的失调被认为是肿瘤发生的主要机制之一,特别是在暴露于外源性DNA损伤剂和正常生理过程中。该提案将揭示一种新的机制介导的DNA损伤信号,从而提供基本的见解调控网络控制细胞凋亡。对这一途径的机制理解将有助于我们破译细胞凋亡在癌症中是如何失调的,并可能确定新的治疗干预靶点。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Qing Zhong其他文献

Qing Zhong的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Qing Zhong', 18)}}的其他基金

Biochemical Dissection and Reconstitution of Autophagic Membrane Fusion
自噬膜融合的生化解剖与重建
  • 批准号:
    9004982
  • 财政年份:
    2015
  • 资助金额:
    $ 31.57万
  • 项目类别:
Molecular Mechanism of Mule in DNA Damage Response and Tumorigenesis
骡DNA损伤反应和肿瘤发生的分子机制
  • 批准号:
    8196709
  • 财政年份:
    2009
  • 资助金额:
    $ 31.57万
  • 项目类别:
Molecular Mechanism of Mule in DNA Damage Response and Tumorigenesis
骡DNA损伤反应和肿瘤发生的分子机制
  • 批准号:
    8769278
  • 财政年份:
    2009
  • 资助金额:
    $ 31.57万
  • 项目类别:
Molecular Mechanism of Mule in DNA Damage Response and Tumorigenesis
骡DNA损伤反应和肿瘤发生的分子机制
  • 批准号:
    8384853
  • 财政年份:
    2009
  • 资助金额:
    $ 31.57万
  • 项目类别:
Molecular Mechanism of Mule in DNA Damage Response and Tumorigenesis
骡DNA损伤反应和肿瘤发生的分子机制
  • 批准号:
    7753898
  • 财政年份:
    2009
  • 资助金额:
    $ 31.57万
  • 项目类别:
Molecular Mechanism of Mule in DNA Damage Response and Tumorigenesis
骡DNA损伤反应和肿瘤发生的分子机制
  • 批准号:
    7989407
  • 财政年份:
    2009
  • 资助金额:
    $ 31.57万
  • 项目类别:

相似海外基金

Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
  • 批准号:
    10506915
  • 财政年份:
    2021
  • 资助金额:
    $ 31.57万
  • 项目类别:
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
  • 批准号:
    10325006
  • 财政年份:
    2021
  • 资助金额:
    $ 31.57万
  • 项目类别:
SBIR Phase I: A New Class of Immobilized Metal Affinity Chromatography Resins
SBIR 第一阶段:一类新型固定金属亲和色谱树脂
  • 批准号:
    1746198
  • 财政年份:
    2018
  • 资助金额:
    $ 31.57万
  • 项目类别:
    Standard Grant
Marine speciation of nickel using immobilized nickel affinity chromatography
使用固定镍亲和色谱法测定镍的海洋形态
  • 批准号:
    512537-2017
  • 财政年份:
    2017
  • 资助金额:
    $ 31.57万
  • 项目类别:
    University Undergraduate Student Research Awards
I-Corps: Commercialization of Immobilized Metal Affinity Chromatography Resins Based on Nanomaterials
I-Corps:基于纳米材料的固定化金属亲和层析树脂的商业化
  • 批准号:
    1404605
  • 财政年份:
    2014
  • 资助金额:
    $ 31.57万
  • 项目类别:
    Standard Grant
Antibody Purification via Affinity Chromatography that Utilizes the Unconventional Nucleotide Binding Site
利用非常规核苷酸结合位点通过亲和色谱法纯化抗体
  • 批准号:
    1263713
  • 财政年份:
    2013
  • 资助金额:
    $ 31.57万
  • 项目类别:
    Continuing Grant
Development of multivalent DNA network based affinity chromatography diagnostics for isolating circulating tumour cells
开发基于多价 DNA 网络的亲和色谱诊断法,用于分离循环肿瘤细胞
  • 批准号:
    425749-2012
  • 财政年份:
    2012
  • 资助金额:
    $ 31.57万
  • 项目类别:
    Postgraduate Scholarships - Master's
Next-Generation Affinity Chromatography with PEGylated Ligands
使用聚乙二醇化配体的新一代亲和色谱法
  • 批准号:
    1159886
  • 财政年份:
    2012
  • 资助金额:
    $ 31.57万
  • 项目类别:
    Standard Grant
Immobilized zirconium ion affinity chromatography for specific enrichment of phosphoproteins
用于磷蛋白特异性富集的固定化锆离子亲和层析
  • 批准号:
    19560760
  • 财政年份:
    2007
  • 资助金额:
    $ 31.57万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Accelerating drug discovery using frontal affinity chromatography/mass spectrometry
使用正面亲和色谱/质谱加速药物发现
  • 批准号:
    234753-2000
  • 财政年份:
    2003
  • 资助金额:
    $ 31.57万
  • 项目类别:
    Collaborative Research and Development Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了